FDA Eyes Research To Back Label Indications For Addiction Medication

FDA is pursuing research that could support a label indication for medication-assisted treatment (MAT), and provide direction for potential long-term use by patients suffering from addiction -- a move that could help promote more widespread use and coverage of MAT, FDA Commissioner Scott Gottlieb said at a Wednesday (Oct. 25) House Energy & Commerce hearing on the opioid crisis. The agency will also be more vocal about debunking the stigma associated with MAT and develop guidelines to develop MAT based...